The 17th EuPFI Conference will gather pharmaceutical scientists, clinicians, regulators, and industry leaders to exchange the latest research and innovations in developing age-appropriate medicines for children.
Fagron will take an active role throughout the event, starting with the pre-conference workshop, where we will help facilitate discussions among participants. During the industry sessions, we will present three of our latest innovations: DiluTab® Mini, an excipient blend for preparing minitablets; SyrSpend® NEO, a suspending vehicle designed for neonatal oral suspensions; and OrPhyllo™, a base for orodispersible film formulations.
Following the conference, we will also participate in the EuPFI members’ meeting, contributing alongside other leading pharmaceutical companies to advance pediatric formulation science in Europe and beyond.
